These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21094354)

  • 1. Safety and efficacy of sirolimus-eluting stent implantation in patients with acute coronary syndrome in the real world.
    Kawaguchi R; Kimura T; Morimoto T; Oshima S; Hoshizaki H; Kawai K; Shiode N; Hiasa Y; Mitsudo K;
    Am J Cardiol; 2010 Dec; 106(11):1550-60. PubMed ID: 21094354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical follow-up after sirolimus-eluting stent versus bare metal stent implantation in patients with acute coronary syndrome.
    Ogita M; Nakamura T; Fujiwara N; Sakakura K; Funayama H; Sugawara Y; Kubo N; Ako J; Momomura S
    J Interv Cardiol; 2009 Jun; 22(3):216-21. PubMed ID: 19490360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).
    Roy P; Bonello L; de Labriolle A; Okabe T; Pinto Slottow TL; Steinberg DH; Torguson R; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2008 Aug; 102(3):292-7. PubMed ID: 18638589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of second-generation everolimus-eluting stents compared to other limus-eluting stents and bare metal stents in patients with acute coronary syndrome.
    Omar A; Torguson R; Kitabata H; Pendyala LK; Loh JP; Magalhaes MA; Satler LF; Suddath WO; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1053-60. PubMed ID: 24619969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry.
    Tada T; Kimura T; Morimoto T; Ono K; Furukawa Y; Nakagawa Y; Nakashima H; Ito A; Siode N; Namura M; Inoue N; Nishikawa H; Nakao K; Mitsudo K;
    Am J Cardiol; 2011 Apr; 107(8):1155-62. PubMed ID: 21296326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.
    Byrne RA; Kastrati A; Massberg S; Wieczorek A; Laugwitz KL; Hadamitzky M; Schulz S; Pache J; Fusaro M; Hausleiter J; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2011 Sep; 58(13):1325-31. PubMed ID: 21920260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
    Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between late incomplete stent apposition after sirolimus eluting stent implantation and clinical outcomes in patients with acute coronary syndrome].
    Zhang RY; Du R; Zhu ZB; Zhang Q; Hu J; Ding FH; Lü AK; Zhang JS; Shen WF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):30-4. PubMed ID: 19671348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes after bioabsorbable polymer- and durable polymer-based sirolimus-eluting stents implantation: two-year follow-up results from a large single-center database.
    Liu HB; Xu B; Yang YJ; Wang Y; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Ma WH; Li JJ; Qiao SB; Chen JL; Li W; Gao RL
    Chin Med J (Engl); 2009 Mar; 122(6):681-6. PubMed ID: 19323934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).
    Hanna NN; Gaglia MA; Torguson R; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Maluenda G; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2010 Aug; 106(4):504-10. PubMed ID: 20691308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
    Kimura T; Morimoto T; Nakagawa Y; Kawai K; Miyazaki S; Muramatsu T; Shiode N; Namura M; Sone T; Oshima S; Nishikawa H; Hiasa Y; Hayashi Y; Nobuyoshi M; Mitudo K;
    Circulation; 2012 Jan; 125(4):584-91. PubMed ID: 22203694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus-eluting stent implantation for ostial left anterior descending coronary artery lesions: three-year outcome from the j-Cypher Registry.
    Kishi K; Kimura T; Morimoto T; Namura M; Muramatsu T; Nishikawa H; Hiasa Y; Isshiki T; Nobuyoshi M; Mitsudo K;
    Circ Cardiovasc Interv; 2011 Aug; 4(4):362-70. PubMed ID: 21712527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
    Kaltoft A; Jensen LO; Maeng M; Tilsted HH; Thayssen P; Bøttcher M; Lassen JF; Krusell LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Sørensen HT; Thuesen L
    J Am Coll Cardiol; 2009 Feb; 53(8):658-64. PubMed ID: 19232897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy.
    Thim T; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Hansen PR; Kelbaek H; Thayssen P; Ravkilde J; Madsen M; Sørensen HT; Thuesen L; Lassen JF
    Eur J Clin Invest; 2012 Oct; 42(10):1047-54. PubMed ID: 22624990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and efficacy of sirolimus-eluting stents in Japanese patients: a single-center cohort study.
    Nakamura M; Yamashita T; Yajima J; Oikawa Y; Ogasawara K; Kirigaya H; Nagashima K; Sawada H; Aizawa T
    J Invasive Cardiol; 2009 Oct; 21(10):526-31. PubMed ID: 19805840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
    Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A
    J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.